Diclofenac as a KMO Inhibitor

EARLY_PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions

Alcohol Use Disorder

Interventions

DRUG

Diclofenac

100 mg

DRUG

Placebo

Sugar pill

Trial Locations (1)

Maryland Psychiatric Research Center (MPRC) Treatment Research Program (TRP), Catonsville

All Listed Sponsors

lead

University of Maryland, Baltimore

OTHER

NCT06029296 - Diclofenac as a KMO Inhibitor | Biotech Hunter | Biotech Hunter